EP1720570A4 - Treatment of dengue hemorrhagic fever - Google Patents

Treatment of dengue hemorrhagic fever

Info

Publication number
EP1720570A4
EP1720570A4 EP05706415A EP05706415A EP1720570A4 EP 1720570 A4 EP1720570 A4 EP 1720570A4 EP 05706415 A EP05706415 A EP 05706415A EP 05706415 A EP05706415 A EP 05706415A EP 1720570 A4 EP1720570 A4 EP 1720570A4
Authority
EP
European Patent Office
Prior art keywords
treatment
hemorrhagic fever
dengue hemorrhagic
dengue
fever
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05706415A
Other languages
German (de)
French (fr)
Other versions
EP1720570A2 (en
Inventor
Maurice Genereux
Jitendra Dixit
Castro Reynaldo Angelo C De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cangene Corp
Original Assignee
Cangene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cangene Corp filed Critical Cangene Corp
Publication of EP1720570A2 publication Critical patent/EP1720570A2/en
Publication of EP1720570A4 publication Critical patent/EP1720570A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
EP05706415A 2004-01-26 2005-01-26 Treatment of dengue hemorrhagic fever Withdrawn EP1720570A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2456294 2004-01-26
PCT/CA2005/000085 WO2005069717A2 (en) 2004-01-26 2005-01-26 The use os anti-rh antibodies for treating acute thrombocytopenia associated with dengue hemorrhagic fever, hepatitis c and other microbial infections

Publications (2)

Publication Number Publication Date
EP1720570A2 EP1720570A2 (en) 2006-11-15
EP1720570A4 true EP1720570A4 (en) 2008-09-03

Family

ID=34800295

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05706415A Withdrawn EP1720570A4 (en) 2004-01-26 2005-01-26 Treatment of dengue hemorrhagic fever

Country Status (2)

Country Link
EP (1) EP1720570A4 (en)
WO (1) WO2005069717A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152589A1 (en) 2008-06-17 2009-12-23 Universidade Federal De Minas Gerais-Ufmg Use of paf receptor for treating infections caused by flaviviridae

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993812A (en) * 1995-09-14 1999-11-30 Cangene Corporation Method of delaying the progression of an infection with the human immunodeficiency virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2807767B1 (en) * 2000-04-12 2005-01-14 Lab Francais Du Fractionnement MONOCLONAL ANTIBODIES ANTI-D

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993812A (en) * 1995-09-14 1999-11-30 Cangene Corporation Method of delaying the progression of an infection with the human immunodeficiency virus

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
BRAVO LULU: "Rational use of immunomodulators in Pediatrics", PIDSPJOURNAL, vol. 2, no. 1, 1998, Philippine, pages 3 - 5, XP002448939, Retrieved from the Internet <URL:http://web.archive.org/web/20041205071617/http://www.pidsp.org/journals/pidspvol2num1.pdf> [retrieved on 20070830] *
CINES D B ET AL: "IMMUNE THROMBOCYTOPENIC PURPURA", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, vol. 346, no. 13, 28 March 2002 (2002-03-28), pages 995 - 1008, XP009049770, ISSN: 1533-4406 *
CINES DOUGLAS B ET AL: "Mechanisms of action of therapeutics in idiopathic thrombocytopenic purpura", JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, NEW YORK, US, vol. 25, no. Suppl 1, 1 December 2003 (2003-12-01), pages S52 - S56, XP008093752, ISSN: 1077-4114 *
DE CASTRO REYNALDO ANGELO C ET AL: "Response of the thrombocytopenia associated with dengue hemorrhagic fever to WinRho (R) SDF: A case series.", BLOOD, vol. 104, no. 11, Part 1, November 2004 (2004-11-01), & 46TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; SAN DIEGO, CA, USA; DECEMBER 04 -07, 2004, pages 568A, XP002448937, ISSN: 0006-4971 *
DE CASTRO REYNALDO ANGELO C ET AL: "Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti-D (Rh(0)-D) immune globulin.", THE AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE APR 2007, vol. 76, no. 4, April 2007 (2007-04-01), pages 737 - 742, XP008083008, ISSN: 0002-9637 *
FABRIS F ET AL: "The treatment of patients with chronic immune thrombocytopenia (ITP): The Padua experience", BRITISH JOURNAL OF HAEMATOLOGY, vol. 93, no. SUPPL. 2, 1996, & SECOND MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION; PARIS, FRANCE; MAY 29-JUNE 1, 1996, pages 183 - 184, XP008093753, ISSN: 0007-1048 *
HERNÁNDEZ F ET AL: "Autoimmune thrombocytopenia associated with hepatitis C virus infection", ACTA HAEMATOLOGICA, S. KARGER, BASEL, CH, vol. 99, no. 4, 1 January 1998 (1998-01-01), pages 217 - 220, XP008093782, ISSN: 0001-5792 *
LINARES M ET AL: "Autoimmune thrombocytopenia and hepatitis C virus infection.", AMERICAN JOURNAL OF HEMATOLOGY DEC 1996, vol. 53, no. 4, December 1996 (1996-12-01), pages 284, XP002487990, ISSN: 0361-8609 *
MARSON P ET AL: "Anti-hepatitis C virus (HCV) in immune thrombocytopenia (ITP): A retrospective analysis in 101 patients", BRITISH JOURNAL OF HAEMATOLOGY, vol. 93, no. SUPPL. 2, 1996, & SECOND MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION; PARIS, FRANCE; MAY 29-JUNE 1, 1996, pages 183, XP008093754, ISSN: 0007-1048 *
MCWILLIAMS N B ET AL: "Acute idiopathic thrombocytopenic purpura in children.", AMERICAN JOURNAL OF HEMATOLOGY 1979, vol. 7, no. 1, 1979, pages 87 - 96, XP002448936, ISSN: 0361-8609 *
OKSENHENDLER E ET AL: "Anti-RH immunoglobulin therapy for human immunodeficiency virus-related immune thrombocytopenic purpura.", BLOOD MAY 1988, vol. 71, no. 5, May 1988 (1988-05-01), pages 1499 - 1502, XP002448935, ISSN: 0006-4971 *
OSTRONOFF M. ET AL: "Serious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages of immunoglobulin.", CLINICAL INFECTIOUS DISEASES : AN OFFICIAL PUBLICATION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA 15 JUN 2003, vol. 36, no. 12, 15 June 2003 (2003-06-15), pages 1623 - 1624, ISSN: 1537-6591 *
RAJAN S ET AL: "Treatment of hepatitis C related thrombocytopenia with interferon alpha.", AMERICAN JOURNAL OF HEMATOLOGY NOV 2001, vol. 68, no. 3, November 2001 (2001-11-01), pages 202 - 209, XP002487989, ISSN: 0361-8609 *
SCARADAVOU A ET AL: "Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients", BLOOD, W.B. SAUNDERS, PHILADELPHIA, VA, US, vol. 89, no. 8, 15 April 1997 (1997-04-15), pages 2689 - 2700, XP002102874, ISSN: 0006-4971 *
TARANTINO ET AL: "Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin", JOURNAL OF PEDIATRICS, MOSBY-YEAR BOOK, ST. LOUIS, MO, US, vol. 134, no. 1, 1 January 1999 (1999-01-01), pages 21 - 26, XP005692586, ISSN: 0022-3476 *
TARANTINO M D ET AL: "TREATMENT OF ACUTE IIMUNE THROMBOCYTOPENIC PURPURA", SEMINARS IN HEMATOLOGY, PHILADELPHIA, PA, US, vol. 35, no. 1, January 1998 (1998-01-01), pages 28 - 35, XP008073665, ISSN: 0037-1963 *
WOLOSKI B.M.R ET AL: "Anti-D in idiopathic thrombocytopenic purpura (ITP)", BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, vol. 105, no. 18, November 1998 (1998-11-01), UK, pages 32 - 44, XP002448934 *
WORLD HEALTH ORGANISATION REGIONAL OFFICE FOR SOUTH EAST ASIA: "Guidelines for the treatment of Dengue Fever/Dengue haemorrhagic fever in small hospitals", 1 January 1999 (1999-01-01), New Dehli *

Also Published As

Publication number Publication date
WO2005069717A2 (en) 2005-08-04
EP1720570A2 (en) 2006-11-15
WO2005069717A3 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
IL212985A0 (en) Therapeutic uses of inhibitors of rtp801
ZA200802501B (en) Indenoisoquinolinone analogs and methods of use thereof
EP1785145A4 (en) Transnasal composition having immediate action and high absorbability
IL191072A0 (en) Therapeutic compositions and methods
EP1874731A4 (en) Quinobenzoxazine analogs and methods of using thereof
GB0506835D0 (en) Therapeutic use of nefopam
GB2430002B (en) Well treatment
GB0515703D0 (en) Therapeutic use of nefopam
GB0426196D0 (en) Methods of treatment
EP1720570A4 (en) Treatment of dengue hemorrhagic fever
EP1962882A4 (en) Compositions and methods for treatment of diabetes
GB0426141D0 (en) Treatment
GB0424085D0 (en) Well treatment
IL185691A0 (en) Novel compounds derived from 5-thioxylose and therapeutic use thereof
GB0408521D0 (en) Treatment of sepsis
GB0423173D0 (en) Treatment of diabetes
ZA200704046B (en) Treatment of burns
GB0428268D0 (en) Pulsing wristband to induce sleep
GB0401819D0 (en) Fracture healing
HU0400952D0 (en) Treatment of anus-cancer
GB0408752D0 (en) Therapeutic treatment
PL365717A1 (en) Forty percent solution of ammonal
GB0422012D0 (en) Methods of treatment
GB0517546D0 (en) Therapeutic methods and compositions
GB0408959D0 (en) Therapeutic agent

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060828

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20080804

17Q First examination report despatched

Effective date: 20090203

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101012